Contraception Clinical Trial
Official title:
A Randomized Controlled Trial: Contraceptive Counseling After an Abortion
Hypothesis: Use of an effective contraceptive six weeks after abortion will be higher in the
treatment group than in the control group.
Primary Aim ·To determine use of an effective contraceptive method six weeks after abortion
in women who choose combined hormonal contraception (CHC) and who receive a three-week
educational phone call as compared to women who do not receive the intervention.
Secondary Aims
- To describe the most common concerns and logistical problems women experience with
initiating and adhering to CHC after abortion.
- To describe the concerns that lead to discontinuation or method change. *To assess
feasibility of conducting a follow-up telephone call in this population This is a
randomized, controlled trial to assess the effect of a three-week follow-up phone call
in women who choose combined hormonal contraception on the day of their abortion at the
San Francisco General Hospital Women's Options Center. Subjects randomized to the
treatment group will receive an interventional phone call three weeks after their
abortion; participants randomized to the control group will not receive the call. All
subjects will receive a follow-up call six weeks after their abortion to assess and
compare method use between the two groups. Calls will be made at three- and six-weeks
post abortion in order to give subjects enough time to initiate CHC and to assess
continuation into the second month of the method. Data will be collected at baseline,
during the intervention for the treatment group and during the final follow-up call for
both groups. The primary outcome is use of an effective contraceptive six weeks after
abortion.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02577601 -
Impact of Combined Hormonal Contraceptives on UPA
|
Phase 4 | |
| Completed |
NCT03153644 -
Improving Contraceptive Care for Women With Medical Conditions
|
||
| Completed |
NCT04112095 -
Adherence With Continuous-dose Oral Contraceptive: Evaluation of Self-Selection and Use
|
Phase 3 | |
| Recruiting |
NCT05521646 -
Implementing Best Practice Postpartum Contraceptive Services Through a Quality Improvement Initiative
|
N/A | |
| Active, not recruiting |
NCT04291001 -
Ovarian Function With ENG Implant and UPA Use
|
Early Phase 1 | |
| Completed |
NCT04568980 -
Assessment of Contraceptive Safety and Effectiveness in Cystic Fibrosis
|
||
| Completed |
NCT03438682 -
Real World Effectiveness and Safety of Hysteroscopic (Essure®) Compared to Laparoscopic Sterilization
|
||
| Active, not recruiting |
NCT01948882 -
Evaluation of Safety and Effectiveness of the Essure (Model ESS505) Device to Prevent Pregnancy in Women
|
N/A | |
| Enrolling by invitation |
NCT04997499 -
Adolescent Subcutaneous (SQ) Injection Video Validation
|
N/A | |
| Recruiting |
NCT03589040 -
Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant
|
Phase 2 | |
| Completed |
NCT04463680 -
Rifampin and the Contraceptive Implant
|
Phase 4 | |
| Completed |
NCT03154125 -
Sayana® Press Extension Study
|
Phase 3 | |
| Withdrawn |
NCT03725358 -
A Cluster-RCT to Increase the Uptake of LARCs Among Adolescent Females and Young Women in Cameroon.
|
N/A | |
| Completed |
NCT02957630 -
"E4/DRSP Endocrine Function, Metabolic Control and Hemostasis Study"
|
Phase 1/Phase 2 | |
| Completed |
NCT02456584 -
Pharmacodynamics and Pharmacokinetics Study of Existing DMPA Contraceptive Methods
|
Phase 1 | |
| Completed |
NCT02718222 -
Impact and Performance of Institutionalizing Immediate Post-partum IUD Services
|
N/A | |
| Recruiting |
NCT02121067 -
LNG-IUS at 2 Weeks Postpartum
|
Phase 4 | |
| Terminated |
NCT02169869 -
Immediate Postplacental IUD Insertion
|
N/A | |
| Recruiting |
NCT02292056 -
Medication Safety and Contraceptive Counseling for Reproductive Aged Women With Psychiatric Conditions
|
N/A | |
| Withdrawn |
NCT01930994 -
Kenya Sino-implant (II) PK Study
|
N/A |